Compare SDGR & BFLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SDGR | BFLY |
|---|---|---|
| Founded | 1990 | 2011 |
| Country | United States | United States |
| Employees | N/A | 220 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Electronics |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2020 | N/A |
| Metric | SDGR | BFLY |
|---|---|---|
| Price | $17.04 | $7.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $21.00 | $5.00 |
| AVG Volume (30 Days) | 1.5M | ★ 11.2M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.14 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $255,869,000.00 | N/A |
| Revenue This Year | $0.76 | $24.01 |
| Revenue Next Year | $4.60 | $19.93 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 23.29 | N/A |
| 52 Week Low | $10.95 | $1.32 |
| 52 Week High | $23.75 | $9.69 |
| Indicator | SDGR | BFLY |
|---|---|---|
| Relative Strength Index (RSI) | 64.68 | 60.62 |
| Support Level | $11.27 | $3.83 |
| Resistance Level | $19.15 | $9.48 |
| Average True Range (ATR) | 1.02 | 0.83 |
| MACD | 0.10 | 0.09 |
| Stochastic Oscillator | 78.21 | 59.36 |
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.